Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Bmal1-knockout mice exhibit reduced cocaine-seeking behaviour and cognitive impairments

  • Castro Zavala, Adriana, 1988-
  • Alegre Zurano, Laia
  • Cantacorps Centellas, Lídia, 1991-
  • Gallego-Landin, Ines
  • Welz, Patrick-Simon
  • Benitah, Salvador A.
  • Valverde Granados, Olga
Brain and Muscle Arnt-like Protein 1 (BMAL1) is an essential component of the molecular clock underlying circadian rhythmicity. Its function has been recently associated with mood and reward processing alterations. We investigated the behavioural and neurobiological impact of Bmal1 gene deletion in mice, and how this could affect rewarding effects of cocaine. Additionally, key clock genes and components of the dopamine system were assessed in several brain areas. Our results evidence behavioural alterations in Bmal1-KO mice, including changes in locomotor activity with impaired habituation to environments, short-term memory and social recognition impairments. In addition, Bmal1-KO mice experienced reduced cocaine-induced sensitisation and rewarding effects of cocaine as well as reduced cocaine-seeking behaviour. Furthermore, Bmal1 deletion influenced the expression of other clock-related genes in the mPFC and striatum, as well as alterations in the expression of dopaminergic elements. Overall, the present article offers a novel and extensive characterisation of Bmal1-KO animals. We suggest that reduced cocaine's rewarding effects in these mutant mice might be related to Bmal1 role as an expression regulator of MAO and TH, two essential enzymes involved in dopamine metabolism., This study was supported by the Ministerio de Ciencia e Innovacion (grant number PID2019-104077RB-100/AEI/10.13039/501100011033), Ministerio de Sanidad (Retic-ISCIII, grant number RD16/017/010; RICORS, grant number RD21/0009/0001, and Plan Nacional sobre Drogas 2018/007). L.A.-Z. and I.G.-L. received a FPI grants (BES-2017-080066 and PRE2020-091923) from the Ministerio de Economia y Competividad. P.S.W. was supported by grant RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033 and by "ESF Investing in your future". The Department of Medicine and Health Sciences (MELIS-UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (CEX2018-000792-M). O.V. is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Cocaine-induced loss of LTD and social impairments are restored by fatty acid amide hydrolase inhibition

  • Alegre Zurano, Laia
  • Cáceres-Rodriguez, Alba
  • Berbegal-Sáez, Paula
  • Lassalle, Olivier
  • Manzoni, Olivier
  • Valverde Granados, Olga
A single dose of cocaine abolishes endocannabinoid-mediated long-term depression (eCB-LTD) in the nucleus accumbens (NAc) within 24 h of administration. However, it is uncertain whether this altered neuroplasticity entails a behavioral deficit. As previously reported, after a single dose of cocaine (20 mg/kg), mice displayed impaired eCB-LTD in the NAc. Such cocaine-induced neuroplastic impairment was accompanied by an altered preference for saccharin and social interactions and a reduction in mRNA levels of the anandamide-catabolizing enzyme NAPE-PLD. The pharmacological increase of anandamide through the fatty acid amide hydrolase (FAAH) inhibitor URB597 (1 mg/kg) reversed the cocaine-induced loss of eCB-LTD in the NAc and restored normal social interaction in cocaine-exposed mice, but it did not affect saccharin preference. Overall, this research underlines the neuroplastic and behavioral alterations occurring after the initial use of cocaine and suggests a potential role for anandamide., This work was supported by the Ministerio de Ciencia e Innovación (#PID2019-104077RB-100 and #PID2022-136962OB-I00 MCIN/AEI/10.13039/501100011033), Ministerio de Sanidad (Government Delegation for the Plan National on Drugs corresponding to Recovery Mechanism Funds, Transformation and Resilience (PRTR) of the European Union #EXP2022/00869, and ISCIII-Feder-RIAPAd-RICORS #RD21/0009/001), the Generalitat de Catalunya, AGAUR (#2021SGR00485) and by the Institut National de la Santé et de la Recherche Médicale (INSERM). L.A-Z received a FPI grant (BES-2017-080066). P.B-S received a FI-AGAUR grant from the Generalitat de Catalunya (2021FI_B00205). The Department of Medicine and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (#CEX2018-000792-M). O.V. is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The role of PPAR-γ in memory deficits induced by prenatal and lactation alcohol exposure in mice

  • García Baos, Alba
  • Pastor, Antonio
  • Gallego-Landin, Ines
  • Torre Fornell, Rafael de la
  • Sanz, Ferran
  • Valverde Granados, Olga
Patients diagnosed with fetal alcohol spectrum disorder (FASD) show persistent cognitive disabilities, including memory deficits. However, the neurobiological substrates underlying these deficits remain unclear. Here, we show that prenatal and lactation alcohol exposure (PLAE) in mice induces FASD-like memory impairments. This is accompanied by a reduction of N-acylethanolamines (NAEs) and peroxisome proliferator-activated receptor gamma (PPAR-γ) in the hippocampus specifically in a childhood-like period (at post-natal day (PD) 25). To determine their role in memory deficits, two pharmacological approaches were performed during this specific period of early life. Thus, memory performance was tested after the repeated administration (from PD25 to PD34) of: i) URB597, to increase NAEs, with GW9662, a PPAR-γ antagonist; ii) pioglitazone, a PPAR-γ agonist. We observed that URB597 suppresses PLAE-induced memory deficits through a PPAR-γ dependent mechanism, since its effects are prevented by GW9662. Direct PPAR-γ activation, using pioglitazone, also ameliorates memory impairments. Lastly, to further investigate the region and cellular specificity, we demonstrate that an early overexpression of PPAR-γ, by means of a viral vector, in hippocampal astrocytes mitigates memory deficits induced by PLAE. Together, our data reveal that disruptions of PPAR-γ signaling during neurodevelopment contribute to PLAE-induced memory dysfunction. In turn, PPAR-γ activation during a childhood-like period is a promising therapeutic approach for memory deficits in the context of early alcohol exposure. Thus, these findings contribute to the gaining insight into the mechanisms that might underlie memory impairments in FASD patients., This work was supported by the Ministerio de Economia y Competitividad (#PID2019-104077RB-100 - MCIN/AEI/10.13039/501100011033), Ministerio de Sanidad (Plan Nacional sobre Drogas #2018/007 and ISCIII-Feder-RIAPAd-RICORS #RD21/0009/001) by the EU NextGeneration and by the Generalitat de Catalunya, AGAUR (#2021SGR00485). AG-B received a FI-AGAUR grant from the Generalitat de Catalunya (#2019FI_B0081). IG-L obtained a grant from the Ministerio de Ciencia e Innovación (#PRE2020-091923) The Department of Medicine and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (#CEX2018-000792-M). OV is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya). The authors wish to thank Xavier Puig-Reyne for the technical support.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol

  • Martín Sánchez, Ana
  • González-Pardo, Héctor
  • Alegre Zurano, Laia
  • Castro Zavala, Adriana, 1988-
  • López-Taboada, Isabel
  • Valverde Granados, Olga
  • Conejo, Nélida M.
Gender is considered as a pivotal determinant of mental health. Indeed, several psychiatric disorders such as anxiety and depression are more common and persistent in women than in men. In the past two decades, impaired brain energy metabolism has been highlighted as a risk factor for the development of these psychiatric disorders. However, comprehensive behavioural and neurobiological studies in brain regions relevant to anxiety and depression symptomatology are scarce. In the present study, we summarize findings describing cannabidiol effects on anxiety and depression in maternally separated female mice as a well-established rodent model of early-life stress associated with many mental disorders. Our results indicate that cannabidiol could prevent anxiolytic- and depressive-related behaviour in early-life stressed female mice. Additionally, maternal separation with early weaning (MSEW) caused long-term changes in brain oxidative metabolism in both nucleus accumbens and amygdalar complex measured by cytochrome c oxidase quantitative histochemistry. However, cannabidiol treatment could not revert brain oxidative metabolism impairment. Moreover, we identified hyperphosphorylation of mTOR and ERK 1/2 proteins in the amygdala but not in the striatum, that could also reflect altered brain intracellular signalling related with to bioenergetic impairment. Altogether, our study supports the hypothesis that MSEW induces profound long-lasting molecular changes in mTOR signalling and brain energy metabolism related to depressive-like and anxiety-like behaviours in female mice, which were partially ameliorated by CBD administration., This work was supported by Ministerio de Economía y Competitividad (grants number PID2019-104077-RB-100 and PSI2017-83038-P), Ministerio de Sanidad, Asuntos Sociales e Igualdad (Retic-ISCIII-RD/16/0017/0010-FEDER) and Plan Nacional Sobre Drogas (#2018/007). The Department of Experimental and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (CEX2018-000792-M).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The FAAH inhibitor URB597 reduces cocaine intake during conditioned punishment and mitigates cocaine seeking during withdrawal

  • Alegre Zurano, Laia
  • García Baos, Alba
  • Castro-Zavala, Adriana
  • Medrano, Mireia
  • Gallego-Landin, Ines
  • Valverde Granados, Olga
The endocannabinoid system is prominently implicated in the control of cocaine reinforcement due to its relevant role in synaptic plasticity and neurotransmitter modulation in the mesocorticolimbic system. The inhibition of fatty acid amide hydrolase (FAAH), and the resulting increase in anandamide and other N-acylethanolamines, represents a promising strategy for reducing drug seeking. In the present study, we aimed to assess the effects of the FAAH inhibitor URB597 (1 mg/kg) on crucial features of cocaine addictive-like behaviour in mice. Therefore, we tested the effects of URB597 on acquisition of cocaine (0.6 mg/kg/inf) self-administration, compulsive-like cocaine intake and cue-induced drug-seeking behaviour during withdrawal. URB597 reduced cocaine intake under conditioned punishment while having no impact on acquisition. This result was associated to increased cannabinoid receptor 1 gene expression in the ventral striatum and medium spiny neurons activation in the nucleus accumbens shell. Moreover, URB597 mitigated cue-induced drug-seeking behaviour during prolonged abstinence and prevented the withdrawal-induced increase in FAAH gene expression in the ventral striatum. In this case, URB597 decreased activation of medium spiny neurons in the nucleus accumbens core. Our findings evidence the prominent role of endocannabinoids in the development of cocaine addictive-like behaviours and support the potential of FAAH inhibition as a therapeutical target for the treatment of cocaine addiction., This work was supported by the Ministerio de Ciencia e Innovación (#PID2019-104077RB-100 and PID2022-136962OB-100 MCIN/AEI/10.13039/501100011033), Ministerio de Sanidad (Plan Nacional sobre Drogas #2018/007, and EXP2022/008695 - funds from the Recovery, Transformation and Resilience Mechanism (PRTR) of the European Union. Funded by the European Union – NextGenerationEU) and by the Generalitat de Catalunya, AGAUR (#2021SGR00485). L.A-Z received a FPI grant (BES-2017-080066) associated to #SAF2016–75966-R grant to O.V. from Ministerio de Economia y Competitividad. A.G-B received a FI-AGAUR grant from the Generalitat de Catalunya (2019FI_B0081). I.G-L. obtained a grant from the Ministerio de Ciencia e Innovación (PRE2020-091923). The Department of Medicine and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (#CEX2018-000792-M). O.V. is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Effects of fast-acting antidepressant drugs on a postpartum depression mice model

  • García Baos, Alba
  • Gallego-Landin, Ines
  • Ferreres-Álvarez, Irene
  • Puig Reyne, Xavier
  • Castro Zavala, Adriana, 1988-
  • Valverde Granados, Olga
  • Martín Sánchez, Ana
Postpartum depression (PPD) is a severe psychiatric disorder with devastating consequences on child development and mother's health. Dysregulation of glutamatergic and GABAergic signalling has been described in the corticolimbic system of PPD patients, who also show a downregulation of allopregnanolone levels in serum. Consequently, a synthetic allopregnanolone-based treatment is the current eligible drug to treat PPD patients. Alternatively, ketamine appears to be a promising medication for preventing PPD, nevertheless the differences in efficacy between both treatments remains unknown due to the lack of comparative studies. On this basis, the present study aims to compare the effectiveness of allopregnanolone and ketamine on a PPD-like mouse model. Our results show that postpartum females undergoing a maternal separation with early weaning (MSEW) protocol show increased despair-like behaviour, anhedonia and disrupted maternal care. Such symptoms are accompanied by lower allopregnanolone serum levels, reduction of vesicular transporters of GABA (VGAT) and glutamate (VGLUT1) in the infralimbic cortex (IL), as well as decreased hippocampal cellular proliferation. Furthermore, both drugs prevent despair-like behaviour while only ketamine reverts anhedonia. Both treatments increase hippocampal neurogenesis, while only allopregnanolone raises VGAT and VGLUT1 markers in IL. These findings suggest that ketamine might be even more effective than allopregnanolone, which points out the necessity of including ketamine in clinical studies for PPD patients. Altogether, we propose a new mice model that recapitulates the core symptomatology and molecular alterations shown in PPD patients, which allows us to further investigate both the neurobiology of PPD and the therapeutic potential of antidepressant drugs., This work was supported by Ministerio de Ciencia e Innovación (grants number PID2019-104077-RB-100/AEI/10.13039/501100011033), Ministerio de Sanidad, Asuntos Sociales e Igualdad (Retic-ISCIII-RD/16/0017/0010-FEDER; RICORS, grant number RD21/0009/0001), and Plan Nacional Sobre Drogas (#2018/007) to O.V. A.G-B received a FI-AGAUR grant from the Generalitat de Catalunya (2019FI_B0081) and I.G-L. obtained a grant from the Ministerio de Ciencia e Innovación (PRE2020-091923). The Department of Medicine and Life Sciences (MELIS-UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (CEX2018-000792-M). O.V. is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya). The authors are indebted to Javier Valle-García (Proteomics and Protein Chemistry Group; Universitat Pompeu Fabra) and Marc González-Colell (Synthetic Biology for Medical Application, Universitat Pompeu Fabra).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Early-life stress exacerbates the effects of WIN55,212-2 and modulates the cannabinoid receptor type 1 expression

  • Martín Sánchez, Ana
  • García Baos, Alba
  • Castro Zavala, Adriana, 1988-
  • Alegre Zurano, Laia
  • Valverde Granados, Olga
Early-life stress induces an abnormal brain development and increases the risk of psychiatric diseases, including depression, anxiety and substance use disorders. We have developed a reliable model for maternal neglect, named maternal separation with early weaning (MSEW) in CD1 mice. In the present study, we evaluated the long-term effects on anxiety-like behaviours, nociception as well as the Iba1-positive microglial cells in this model in comparison to standard nest (SN) mice. Moreover, we investigated whether MSEW alters the cannabinoid agonist WIN55,212-2 effects regarding reward, spatial and emotional memories, tolerance to different cannabinoid responses, and physical dependence. Adult male offspring of MSEW group showed impaired responses on spatial and emotional memories after a repeated WIN55,212-2 treatment. These behavioural impairments were associated with an increase in basolateral amygdala and hippocampal CB1-expressing fibres and higher number of CB1-containing cells in cerebellum. Additionally, MSEW promotes a higher number of Iba1-positive microglial cells in basolateral amygdala and cerebellum. As for the cannabinoid-induced effects, rearing conditions did not influence the rewarding effects of WIN55,212-2 in the conditioned place preference paradigm. However, MSEW mice showed a delay in the development of tolerance to the cannabinoid effects. Moreover, CB1-positive fibres were reduced in limbic areas in MSEW mice after cannabinoid withdrawal precipitated with the CB1 antagonist SR141617A. These findings support that early-life stress promotes behavioural and molecular changes in the sensitivity to cannabinoids, which are mediated by alterations in CB1 signalling in limbic areas and it induces an increased Iba1-microglial marker which could interfere in emotional memories formation., This study was supported by the Ministerio de Economia y Competitividad (grant number SAF2016-75966-R-FEDER and PID2019-104077RB-100), Ministerio de Sanidad (Retic-ISCIII, RD16/017/010 and Plan Nacional sobre Drogas 2018/007). L.A.Z received a FPI grant (BES-2017-080066) from Ministerio de Economia y Competitividad. A.G-B received a FI-AGAUR grant from the Generalitat de Catalunya (2019FI_B0081). A.C-Z received CONACYT grant (276577) from the Mexican government.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Reviewing the role of the endocannabinoid system in the pathophysiology of depression

  • Gallego-Landin, Ines
  • García Baos, Alba
  • Castro Zavala, Adriana, 1988-
  • Valverde Granados, Olga
Major depressive disorder is a high-impact, debilitating disease and it is currently considered the most prevalent mental illness. It is associated with disability, as well as increased morbidity and mortality. Despite its significant repercussions in our society, its exact pathophysiology remains unclear and therefore, available antidepressant treatment options are limited and, in some cases, ineffective. In the past years, research has focused on the development of a multifactorial theory of depression. Simultaneously, evidence supporting the role of the endocannabinoid system in the neurobiology of neuropsychiatric diseases has emerged. Studies have shown that the endocannabinoid system strongly impacts neurotransmission, and the neuroendocrine and neuroimmune systems, which are known to be dysfunctional in depressive patients. Accordingly, common antidepressants were shown to have a direct impact on the expression of cannabinoid receptors throughout the brain. Therefore, the relationship between the endocannabinoid system and major depressive disorder is worth consideration. Nevertheless, most studies focus on smaller pieces of what is undoubtedly a larger mosaic of interdependent processes. Therefore, the present review summarizes the existing literature regarding the role of the endocannabinoid system in depression aiming to integrate this information into a holistic picture for a better understanding of the relationship between the two., This work was supported by Ministerio de Economía y Competitividad: PID 2019-104077-RB-100/AEI/10.3389/fphar.2021.762738, Ministerio de Sanidad, Asuntos Sociales e Igualdad (Retic-ISCIII-RD/16/0017/0010-FEDER and Plan Nacional Sobre Drogas (#2018/007). AG-B received a FI-AGAUR grant from the Generalitat de Catalunya (2019FI_B0081). The Department of Experimental and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (CEX 2018-000792-M).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cocaine-induced loss of LTD and social impairments are restored by fatty acid amide hydrolase inhibition

  • Alegre Zurano, Laia
  • Cáceres-Rodriguez, Alba
  • Berbegal-Sáez, Paula
  • Lassalle, Olivier
  • Manzoni, Olivier
  • Valverde Granados, Olga
A single dose of cocaine abolishes endocannabinoid-mediated long-term depression (eCB-LTD) in the nucleus accumbens (NAc) within 24 h of administration. However, it is uncertain whether this altered neuroplasticity entails a behavioral deficit. As previously reported, after a single dose of cocaine (20 mg/kg), mice displayed impaired eCB-LTD in the NAc. Such cocaine-induced neuroplastic impairment was accompanied by an altered preference for saccharin and social interactions and a reduction in mRNA levels of the anandamide-catabolizing enzyme NAPE-PLD. The pharmacological increase of anandamide through the fatty acid amide hydrolase (FAAH) inhibitor URB597 (1 mg/kg) reversed the cocaine-induced loss of eCB-LTD in the NAc and restored normal social interaction in cocaine-exposed mice, but it did not affect saccharin preference. Overall, this research underlines the neuroplastic and behavioral alterations occurring after the initial use of cocaine and suggests a potential role for anandamide., This work was supported by the Ministerio de Ciencia e Innovación (#PID2019-104077RB-100 and #PID2022-136962OB-I00 MCIN/AEI/10.13039/501100011033), Ministerio de Sanidad (Government Delegation for the Plan National on Drugs corresponding to Recovery Mechanism Funds, Transformation and Resilience (PRTR) of the European Union #EXP2022/00869, and ISCIII-Feder-RIAPAd-RICORS #RD21/0009/001), the Generalitat de Catalunya, AGAUR (#2021SGR00485) and by the Institut National de la Santé et de la Recherche Médicale (INSERM). L.A-Z received a FPI grant (BES-2017-080066). P.B-S received a FI-AGAUR grant from the Generalitat de Catalunya (2021FI_B00205). The Department of Medicine and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (#CEX2018-000792-M). O.V. is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Effects of fast-acting antidepressant drugs on a postpartum depression mice model

  • García Baos, Alba
  • Gallego-Landin, Ines
  • Ferreres-Álvarez, Irene
  • Puig Reyne, Xavier
  • Castro Zavala, Adriana, 1988-
  • Valverde Granados, Olga
  • Martín Sánchez, Ana
Postpartum depression (PPD) is a severe psychiatric disorder with devastating consequences on child development and mother's health. Dysregulation of glutamatergic and GABAergic signalling has been described in the corticolimbic system of PPD patients, who also show a downregulation of allopregnanolone levels in serum. Consequently, a synthetic allopregnanolone-based treatment is the current eligible drug to treat PPD patients. Alternatively, ketamine appears to be a promising medication for preventing PPD, nevertheless the differences in efficacy between both treatments remains unknown due to the lack of comparative studies. On this basis, the present study aims to compare the effectiveness of allopregnanolone and ketamine on a PPD-like mouse model. Our results show that postpartum females undergoing a maternal separation with early weaning (MSEW) protocol show increased despair-like behaviour, anhedonia and disrupted maternal care. Such symptoms are accompanied by lower allopregnanolone serum levels, reduction of vesicular transporters of GABA (VGAT) and glutamate (VGLUT1) in the infralimbic cortex (IL), as well as decreased hippocampal cellular proliferation. Furthermore, both drugs prevent despair-like behaviour while only ketamine reverts anhedonia. Both treatments increase hippocampal neurogenesis, while only allopregnanolone raises VGAT and VGLUT1 markers in IL. These findings suggest that ketamine might be even more effective than allopregnanolone, which points out the necessity of including ketamine in clinical studies for PPD patients. Altogether, we propose a new mice model that recapitulates the core symptomatology and molecular alterations shown in PPD patients, which allows us to further investigate both the neurobiology of PPD and the therapeutic potential of antidepressant drugs., This work was supported by Ministerio de Ciencia e Innovación (grants number PID2019-104077-RB-100/AEI/10.13039/501100011033), Ministerio de Sanidad, Asuntos Sociales e Igualdad (Retic-ISCIII-RD/16/0017/0010-FEDER; RICORS, grant number RD21/0009/0001), and Plan Nacional Sobre Drogas (#2018/007) to O.V. A.G-B received a FI-AGAUR grant from the Generalitat de Catalunya (2019FI_B0081) and I.G-L. obtained a grant from the Ministerio de Ciencia e Innovación (PRE2020-091923). The Department of Medicine and Life Sciences (MELIS-UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (CEX2018-000792-M). O.V. is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya). The authors are indebted to Javier Valle-García (Proteomics and Protein Chemistry Group; Universitat Pompeu Fabra) and Marc González-Colell (Synthetic Biology for Medical Application, Universitat Pompeu Fabra).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The role of PPAR-γ in memory deficits induced by prenatal and lactation alcohol exposure in mice

  • García Baos, Alba
  • Pastor, Antonio
  • Gallego-Landin, Ines
  • Torre Fornell, Rafael de la
  • Sanz, Ferran
  • Valverde Granados, Olga
Patients diagnosed with fetal alcohol spectrum disorder (FASD) show persistent cognitive disabilities, including memory deficits. However, the neurobiological substrates underlying these deficits remain unclear. Here, we show that prenatal and lactation alcohol exposure (PLAE) in mice induces FASD-like memory impairments. This is accompanied by a reduction of N-acylethanolamines (NAEs) and peroxisome proliferator-activated receptor gamma (PPAR-γ) in the hippocampus specifically in a childhood-like period (at post-natal day (PD) 25). To determine their role in memory deficits, two pharmacological approaches were performed during this specific period of early life. Thus, memory performance was tested after the repeated administration (from PD25 to PD34) of: i) URB597, to increase NAEs, with GW9662, a PPAR-γ antagonist; ii) pioglitazone, a PPAR-γ agonist. We observed that URB597 suppresses PLAE-induced memory deficits through a PPAR-γ dependent mechanism, since its effects are prevented by GW9662. Direct PPAR-γ activation, using pioglitazone, also ameliorates memory impairments. Lastly, to further investigate the region and cellular specificity, we demonstrate that an early overexpression of PPAR-γ, by means of a viral vector, in hippocampal astrocytes mitigates memory deficits induced by PLAE. Together, our data reveal that disruptions of PPAR-γ signaling during neurodevelopment contribute to PLAE-induced memory dysfunction. In turn, PPAR-γ activation during a childhood-like period is a promising therapeutic approach for memory deficits in the context of early alcohol exposure. Thus, these findings contribute to the gaining insight into the mechanisms that might underlie memory impairments in FASD patients., This work was supported by the Ministerio de Economia y Competitividad (#PID2019-104077RB-100 - MCIN/AEI/10.13039/501100011033), Ministerio de Sanidad (Plan Nacional sobre Drogas #2018/007 and ISCIII-Feder-RIAPAd-RICORS #RD21/0009/001) by the EU NextGeneration and by the Generalitat de Catalunya, AGAUR (#2021SGR00485). AG-B received a FI-AGAUR grant from the Generalitat de Catalunya (#2019FI_B0081). IG-L obtained a grant from the Ministerio de Ciencia e Innovación (#PRE2020-091923) The Department of Medicine and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (#CEX2018-000792-M). OV is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya). The authors wish to thank Xavier Puig-Reyne for the technical support.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Reviewing the role of the endocannabinoid system in the pathophysiology of depression

  • Gallego-Landin, Ines
  • García Baos, Alba
  • Castro Zavala, Adriana, 1988-
  • Valverde Granados, Olga
Major depressive disorder is a high-impact, debilitating disease and it is currently considered the most prevalent mental illness. It is associated with disability, as well as increased morbidity and mortality. Despite its significant repercussions in our society, its exact pathophysiology remains unclear and therefore, available antidepressant treatment options are limited and, in some cases, ineffective. In the past years, research has focused on the development of a multifactorial theory of depression. Simultaneously, evidence supporting the role of the endocannabinoid system in the neurobiology of neuropsychiatric diseases has emerged. Studies have shown that the endocannabinoid system strongly impacts neurotransmission, and the neuroendocrine and neuroimmune systems, which are known to be dysfunctional in depressive patients. Accordingly, common antidepressants were shown to have a direct impact on the expression of cannabinoid receptors throughout the brain. Therefore, the relationship between the endocannabinoid system and major depressive disorder is worth consideration. Nevertheless, most studies focus on smaller pieces of what is undoubtedly a larger mosaic of interdependent processes. Therefore, the present review summarizes the existing literature regarding the role of the endocannabinoid system in depression aiming to integrate this information into a holistic picture for a better understanding of the relationship between the two., This work was supported by Ministerio de Economía y Competitividad: PID 2019-104077-RB-100/AEI/10.3389/fphar.2021.762738, Ministerio de Sanidad, Asuntos Sociales e Igualdad (Retic-ISCIII-RD/16/0017/0010-FEDER and Plan Nacional Sobre Drogas (#2018/007). AG-B received a FI-AGAUR grant from the Generalitat de Catalunya (2019FI_B0081). The Department of Experimental and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (CEX 2018-000792-M).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Early-life stress exacerbates the effects of WIN55,212-2 and modulates the cannabinoid receptor type 1 expression

  • Martín Sánchez, Ana
  • García Baos, Alba
  • Castro Zavala, Adriana, 1988-
  • Alegre Zurano, Laia
  • Valverde Granados, Olga
Early-life stress induces an abnormal brain development and increases the risk of psychiatric diseases, including depression, anxiety and substance use disorders. We have developed a reliable model for maternal neglect, named maternal separation with early weaning (MSEW) in CD1 mice. In the present study, we evaluated the long-term effects on anxiety-like behaviours, nociception as well as the Iba1-positive microglial cells in this model in comparison to standard nest (SN) mice. Moreover, we investigated whether MSEW alters the cannabinoid agonist WIN55,212-2 effects regarding reward, spatial and emotional memories, tolerance to different cannabinoid responses, and physical dependence. Adult male offspring of MSEW group showed impaired responses on spatial and emotional memories after a repeated WIN55,212-2 treatment. These behavioural impairments were associated with an increase in basolateral amygdala and hippocampal CB1-expressing fibres and higher number of CB1-containing cells in cerebellum. Additionally, MSEW promotes a higher number of Iba1-positive microglial cells in basolateral amygdala and cerebellum. As for the cannabinoid-induced effects, rearing conditions did not influence the rewarding effects of WIN55,212-2 in the conditioned place preference paradigm. However, MSEW mice showed a delay in the development of tolerance to the cannabinoid effects. Moreover, CB1-positive fibres were reduced in limbic areas in MSEW mice after cannabinoid withdrawal precipitated with the CB1 antagonist SR141617A. These findings support that early-life stress promotes behavioural and molecular changes in the sensitivity to cannabinoids, which are mediated by alterations in CB1 signalling in limbic areas and it induces an increased Iba1-microglial marker which could interfere in emotional memories formation., This study was supported by the Ministerio de Economia y Competitividad (grant number SAF2016-75966-R-FEDER and PID2019-104077RB-100), Ministerio de Sanidad (Retic-ISCIII, RD16/017/010 and Plan Nacional sobre Drogas 2018/007). L.A.Z received a FPI grant (BES-2017-080066) from Ministerio de Economia y Competitividad. A.G-B received a FI-AGAUR grant from the Generalitat de Catalunya (2019FI_B0081). A.C-Z received CONACYT grant (276577) from the Mexican government.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The FAAH inhibitor URB597 reduces cocaine intake during conditioned punishment and mitigates cocaine seeking during withdrawal

  • Alegre Zurano, Laia
  • García Baos, Alba
  • Castro-Zavala, Adriana
  • Medrano, Mireia
  • Gallego-Landin, Ines
  • Valverde Granados, Olga
The endocannabinoid system is prominently implicated in the control of cocaine reinforcement due to its relevant role in synaptic plasticity and neurotransmitter modulation in the mesocorticolimbic system. The inhibition of fatty acid amide hydrolase (FAAH), and the resulting increase in anandamide and other N-acylethanolamines, represents a promising strategy for reducing drug seeking. In the present study, we aimed to assess the effects of the FAAH inhibitor URB597 (1 mg/kg) on crucial features of cocaine addictive-like behaviour in mice. Therefore, we tested the effects of URB597 on acquisition of cocaine (0.6 mg/kg/inf) self-administration, compulsive-like cocaine intake and cue-induced drug-seeking behaviour during withdrawal. URB597 reduced cocaine intake under conditioned punishment while having no impact on acquisition. This result was associated to increased cannabinoid receptor 1 gene expression in the ventral striatum and medium spiny neurons activation in the nucleus accumbens shell. Moreover, URB597 mitigated cue-induced drug-seeking behaviour during prolonged abstinence and prevented the withdrawal-induced increase in FAAH gene expression in the ventral striatum. In this case, URB597 decreased activation of medium spiny neurons in the nucleus accumbens core. Our findings evidence the prominent role of endocannabinoids in the development of cocaine addictive-like behaviours and support the potential of FAAH inhibition as a therapeutical target for the treatment of cocaine addiction., This work was supported by the Ministerio de Ciencia e Innovación (#PID2019-104077RB-100 and PID2022-136962OB-100 MCIN/AEI/10.13039/501100011033), Ministerio de Sanidad (Plan Nacional sobre Drogas #2018/007, and EXP2022/008695 - funds from the Recovery, Transformation and Resilience Mechanism (PRTR) of the European Union. Funded by the European Union – NextGenerationEU) and by the Generalitat de Catalunya, AGAUR (#2021SGR00485). L.A-Z received a FPI grant (BES-2017-080066) associated to #SAF2016–75966-R grant to O.V. from Ministerio de Economia y Competitividad. A.G-B received a FI-AGAUR grant from the Generalitat de Catalunya (2019FI_B0081). I.G-L. obtained a grant from the Ministerio de Ciencia e Innovación (PRE2020-091923). The Department of Medicine and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (#CEX2018-000792-M). O.V. is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Bmal1-knockout mice exhibit reduced cocaine-seeking behaviour and cognitive impairments

  • Castro Zavala, Adriana, 1988-
  • Alegre Zurano, Laia
  • Cantacorps Centellas, Lídia, 1991-
  • Gallego-Landin, Ines
  • Welz, Patrick-Simon
  • Benitah, Salvador A.
  • Valverde Granados, Olga
Brain and Muscle Arnt-like Protein 1 (BMAL1) is an essential component of the molecular clock underlying circadian rhythmicity. Its function has been recently associated with mood and reward processing alterations. We investigated the behavioural and neurobiological impact of Bmal1 gene deletion in mice, and how this could affect rewarding effects of cocaine. Additionally, key clock genes and components of the dopamine system were assessed in several brain areas. Our results evidence behavioural alterations in Bmal1-KO mice, including changes in locomotor activity with impaired habituation to environments, short-term memory and social recognition impairments. In addition, Bmal1-KO mice experienced reduced cocaine-induced sensitisation and rewarding effects of cocaine as well as reduced cocaine-seeking behaviour. Furthermore, Bmal1 deletion influenced the expression of other clock-related genes in the mPFC and striatum, as well as alterations in the expression of dopaminergic elements. Overall, the present article offers a novel and extensive characterisation of Bmal1-KO animals. We suggest that reduced cocaine's rewarding effects in these mutant mice might be related to Bmal1 role as an expression regulator of MAO and TH, two essential enzymes involved in dopamine metabolism., This study was supported by the Ministerio de Ciencia e Innovacion (grant number PID2019-104077RB-100/AEI/10.13039/501100011033), Ministerio de Sanidad (Retic-ISCIII, grant number RD16/017/010; RICORS, grant number RD21/0009/0001, and Plan Nacional sobre Drogas 2018/007). L.A.-Z. and I.G.-L. received a FPI grants (BES-2017-080066 and PRE2020-091923) from the Ministerio de Economia y Competividad. P.S.W. was supported by grant RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033 and by "ESF Investing in your future". The Department of Medicine and Health Sciences (MELIS-UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (CEX2018-000792-M). O.V. is recipient of an ICREA Academia Award (Institució Catalana de Recerca i Estudis Avançats, Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol

  • Martín Sánchez, Ana
  • González-Pardo, Héctor
  • Alegre Zurano, Laia
  • Castro Zavala, Adriana, 1988-
  • López-Taboada, Isabel
  • Valverde Granados, Olga
  • Conejo, Nélida M.
Gender is considered as a pivotal determinant of mental health. Indeed, several psychiatric disorders such as anxiety and depression are more common and persistent in women than in men. In the past two decades, impaired brain energy metabolism has been highlighted as a risk factor for the development of these psychiatric disorders. However, comprehensive behavioural and neurobiological studies in brain regions relevant to anxiety and depression symptomatology are scarce. In the present study, we summarize findings describing cannabidiol effects on anxiety and depression in maternally separated female mice as a well-established rodent model of early-life stress associated with many mental disorders. Our results indicate that cannabidiol could prevent anxiolytic- and depressive-related behaviour in early-life stressed female mice. Additionally, maternal separation with early weaning (MSEW) caused long-term changes in brain oxidative metabolism in both nucleus accumbens and amygdalar complex measured by cytochrome c oxidase quantitative histochemistry. However, cannabidiol treatment could not revert brain oxidative metabolism impairment. Moreover, we identified hyperphosphorylation of mTOR and ERK 1/2 proteins in the amygdala but not in the striatum, that could also reflect altered brain intracellular signalling related with to bioenergetic impairment. Altogether, our study supports the hypothesis that MSEW induces profound long-lasting molecular changes in mTOR signalling and brain energy metabolism related to depressive-like and anxiety-like behaviours in female mice, which were partially ameliorated by CBD administration., This work was supported by Ministerio de Economía y Competitividad (grants number PID2019-104077-RB-100 and PSI2017-83038-P), Ministerio de Sanidad, Asuntos Sociales e Igualdad (Retic-ISCIII-RD/16/0017/0010-FEDER) and Plan Nacional Sobre Drogas (#2018/007). The Department of Experimental and Health Sciences (UPF) is a “Unidad de Excelencia María de Maeztu” funded by the AEI (CEX2018-000792-M).